BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$105.92
−4.29%Next report
Analyst consensus
- Next report date
- Oct 6, 2026
- EPS estimate
- $0.16
- Revenue estimate
- $116.1M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.15
- EPS estimate
- $0.18
- Revenue actual
- $109.4M
- Revenue estimate
- $109.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +248.1%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $126
- PT range
- $120 – $130
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.18 | $0.15 | Miss -18.17% | $109.4M |
| May 6, 2026 | $0.03 | $0.34 | Beat 981.77% | $108.4M |
| Mar 4, 2026 | $0.07 | $0.11 | Beat 57.14% | $96.1M |
| Dec 9, 2025 | $0.14 | $0.10 | Miss -28.32% | $83.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 6, 2026